Tilray Brands, Inc. (TLRY) |
|
3.9 -0.13 (-3.23%)
|
08-08 01:36 |
|
Open: |
3.88 |
Pre. Close: |
4.03 |
|
High:
|
4.02 |
Low:
|
3.8 |
|
Volume:
|
24,705,521 |
Market Cap:
|
2,262(M) |
|
|
|
|
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.03 - 4.05 |
4.05 - 4.07 |
|
Low:
|
3.75 - 3.77 |
3.77 - 3.79 |
|
Close:
|
3.86 - 3.9 |
3.9 - 3.94 |
|
Technical analysis |
as of: 2022-08-05 4:25:51 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 4.84 One year: 5.66 |
| Support: |
Support1: 3.43 Support2: 3 |
| Resistance: |
Resistance1: 4.15 Resistance2: 4.84 |
| Pivot: |
3.65  |
| Moving Average: |
MA(5): 3.82 MA(20): 3.56
MA(100): 4.62 MA(250): 7.4 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 79 %D(3): 73.2 |
| RSI: |
RSI(14): 55.7 |
| 52-week: |
High: 14.27 Low: 3 |
| Average Vol(K): |
3-Month: 24,612 (K) 10-Days: 26,996 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TLRY ] has closed below upper band by 23.0%. Bollinger Bands are 48.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 03 Aug 2022
Tilray Brands inks CBD beverage distribution deal with Southern Glazer's (NASDAQ:TLRY) - Seeking Alpha
Tue, 02 Aug 2022
Why Are Cannabis Stocks TLRY, CGC, CRON Up Today? - InvestorPlace
Mon, 01 Aug 2022
Truist Financial Corp Sells 3355 Shares of Tilray Inc (NASDAQ:TLRY) - Defense World
Fri, 29 Jul 2022
Tilray, Inc. (TLRY) Q4 2022 Earnings Call Transcript - The Motley Fool
Tue, 26 Jul 2022
Cannabis Stocks ACB, HEXO, CGC, TLRY Slump Despite Senate Meeting - InvestorPlace
Thu, 21 Jul 2022
Cannabis Stocks TLRY, SNDL, CGC, ACB, GRWG Down as Senators Unveil New Bill - InvestorPlace
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
531 (M) |
| Shares Float |
479 (M) |
|
% Held by Insiders
|
4.1 (%) |
|
% Held by Institutions
|
15.3 (%) |
|
Shares Short
|
70,100 (K) |
|
Shares Short P.Month
|
66,190 (K) |
Stock Financials |
|
EPS
|
0.34 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
9.61 |
|
Profit Margin (%)
|
6.7 |
|
Operating Margin (%)
|
-28.2 |
|
Return on Assets (ttm)
|
-2.8 |
|
Return on Equity (ttm)
|
1.9 |
|
Qtrly Rev. Growth
|
22.6 |
|
Gross Profit (p.s.)
|
0.23 |
|
Sales Per Share
|
1.16 |
|
EBITDA (p.s.)
|
-0.07 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-148 (M) |
|
Levered Free Cash Flow
|
-5 (M) |
Stock Valuations |
|
PE Ratio
|
11.47 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.4 |
|
Price to Sales
|
3.35 |
|
Price to Cash Flow
|
-13.95 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
